A case of etomidate use in management of adrenocortical carcinoma with hypercortisolemia
Adrenocortical carcinoma (ACC) is rare with an incidence of 0.7-2.0 per million per year. Approximately 60% of cases present with hy-percortisolism, and rapidly progressing Cushing’s syndrome with or without virilisation is the most frequent presentation of ACC. Surgical intervention, aimed at remov...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elmer Press,
2020
|
| Subjects: | |
| Online Access: | View Fulltext in Publisher View in Scopus |